Top Suppliers:I want be here

359886-84-3

359886-84-3 structure
359886-84-3 structure
  • Name: Cdk4/6 Inhibitor IV
  • Chemical Name: CINK4
  • CAS Number: 359886-84-3
  • Molecular Formula: C27H32N6O
  • Molecular Weight: 456.583
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage CDK
  • Create Date: 2020-01-12 13:50:41
  • Modify Date: 2024-01-02 11:39:25
  • Cdk4/6 Inhibitor IV is a cell-permeable triaminopyrimidine compound acting as a reversible and ATP-competitive inhibitor of Cdk4/6 (IC50 = 1.5 ��M and 5.6 ��M for Cdk4/D1 and Cdk6/D1, respectively)

Name CINK4
Synonyms CINK4
trans-4-({2-[(1-Benzyl-1H-indol-5-yl)amino]-6-(ethylamino)-4-pyrimidinyl}amino)cyclohexanol
Cyclohexanol, 4-[[6-(ethylamino)-2-[[1-(phenylmethyl)-1H-indol-5-yl]amino]-4-pyrimidinyl]amino]-, trans-
trans-4-[[6-(ethylamino)-2-[[1-(phenylmethyl)-1H-indol-5-yl]amino]-4-pyrimidinyl]amino]-cyclohexanol
CGP 82996
CGP-82996
Description Cdk4/6 Inhibitor IV is a cell-permeable triaminopyrimidine compound acting as a reversible and ATP-competitive inhibitor of Cdk4/6 (IC50 = 1.5 ��M and 5.6 ��M for Cdk4/D1 and Cdk6/D1, respectively)
In Vitro Cdk4/6 Inhibitor IV is a cell-permeable triaminopyrimidine compound acting as a reversible and ATP-competitive inhibitor of Cdk4/6 (IC50 = 1.5 ��M and 5.6 ��M for Cdk4/D1 and Cdk6/D1, respectively) with selectivity over Cdk5/p35 (IC50 = 25 ��M), v-abl, c-met, IGF-1R and IR (IC50 > 10 ��M), Cdk2/A, Cdk2/E, Cdk4/D2, Cdk6/D2 (IC50 > 50 ��M) and Cdk1/B (IC50 > 100 ��M). Cdk4/6 Inhibitor IV exhibits blocking of pRb phosphorylation at Ser780 and Ser795, induce cell cycle arrest (G0/G1), and apoptosis in U2OS and MRC-5 cells at 5 - 10 ��M. Further, suppresses tumor growth in Xenograft mouse model (30 mg/kg, i.p.).
Density 1.3±0.1 g/cm3
Boiling Point 755.4±70.0 °C at 760 mmHg
Molecular Formula C27H32N6O
Molecular Weight 456.583
Flash Point 410.6±35.7 °C
Exact Mass 456.263763
LogP 4.01
Vapour Pressure 0.0±2.7 mmHg at 25°C
Index of Refraction 1.680
Symbol GHS06
GHS06
Signal Word Danger
Hazard Statements H301
Precautionary Statements P301 + P310 + P330
RIDADR UN 2811 6.1 / PGIII